{
    "table_name": "CPTAC.QUANT_PHOSPHOPROTEOME_AML_EX_VIVO_DRUG_RESPONSE_PRIMARY_COHORT_PDC_CURRENT",
    "table_fullname": "CPTAC_PDC.CPTAC.QUANT_PHOSPHOPROTEOME_AML_EX_VIVO_DRUG_RESPONSE_PRIMARY_COHORT_PDC_CURRENT",
    "column_names": [
        "study_name",
        "phosphorylation_sites",
        "aliquot_id",
        "aliquot_submitter_id",
        "protein_abundance_log2ratio",
        "aliquot_run_metadata_id",
        "sample_id",
        "refseq_id",
        "case_id"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -1.1584,
            "refseq_id": "NP_001005.1",
            "phosphorylation_sites": "s146"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -2.225,
            "refseq_id": "NP_001014972.1",
            "phosphorylation_sites": "s1401"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -2.4866,
            "refseq_id": "NP_001025459.1",
            "phosphorylation_sites": "s351s355"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -2.1708,
            "refseq_id": "NP_001028886.1",
            "phosphorylation_sites": "s58"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -1.8185,
            "refseq_id": "NP_001127836.1",
            "phosphorylation_sites": "s636"
        }
    ]
}